Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race.


Journal

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
ISSN: 1534-4436
Titre abrégé: Ann Allergy Asthma Immunol
Pays: United States
ID NLM: 9503580

Informations de publication

Date de publication:
08 2020
Historique:
received: 18 10 2019
revised: 09 03 2020
accepted: 17 03 2020
pubmed: 1 4 2020
medline: 8 10 2020
entrez: 1 4 2020
Statut: ppublish

Résumé

Serum immunoglobulin G (IgG) concentrations are integral to the workup of immune deficiencies and IgG4-related disease (IgG4-RD). Demographic differences in IgG concentrations are poorly described but can influence test interpretation, contribute to racial disparities in primary immunodeficiency diagnosis, and explain demographic differences in IgG concentrations in IgG4-RD. To assess differences in IgG and IgG subclass concentrations according to sex and race. We identified patients with IgG and IgG subclass concentrations measured in a large health care system. Multivariate-adjusted differences in IgG and IgG subclass concentrations and the proportion of subjects with results outside of reference ranges according to sex and race were estimated. Of the 12,851 patients, the mean age was 54.7 years and 7917 (62%) were female. Of these, 11,673 (91%) were white, 611 (5%) were black, and 302 (2%) were Asian. Compared with the mean concentrations of white patients, Asian and black patients had higher mean concentrations of IgG (1340.0 and 1504.4 vs 988.1 mg/dL, P < .001), IgG1 (782.0 and 938.4 vs 592.4 mg/dL, P < .001), IgG2 (493.5 and 384.2 vs 305 mg/dL, P < .001), IgG3 (76.6 and 91.9 vs 55.9 mg/dL, P < .001), and IgG4 (140.4 and 53.6 vs 41.6 mg/dL, P < .001). Immunoglobin G subclass 4 concentrations were higher in males than those in females (56.3 vs 37.4 mg/dL, P < .001). Similar observations were made when comparing the proportions of patients with results outside of reference ranges and after stratifying by diagnosis. Immunoglobin G and IgG subclass concentrations differ according to sex and race. These findings may have implications for the interpretation of these test results but require confirmation in diverse, healthy populations.

Sections du résumé

BACKGROUND
Serum immunoglobulin G (IgG) concentrations are integral to the workup of immune deficiencies and IgG4-related disease (IgG4-RD). Demographic differences in IgG concentrations are poorly described but can influence test interpretation, contribute to racial disparities in primary immunodeficiency diagnosis, and explain demographic differences in IgG concentrations in IgG4-RD.
OBJECTIVE
To assess differences in IgG and IgG subclass concentrations according to sex and race.
METHODS
We identified patients with IgG and IgG subclass concentrations measured in a large health care system. Multivariate-adjusted differences in IgG and IgG subclass concentrations and the proportion of subjects with results outside of reference ranges according to sex and race were estimated.
RESULTS
Of the 12,851 patients, the mean age was 54.7 years and 7917 (62%) were female. Of these, 11,673 (91%) were white, 611 (5%) were black, and 302 (2%) were Asian. Compared with the mean concentrations of white patients, Asian and black patients had higher mean concentrations of IgG (1340.0 and 1504.4 vs 988.1 mg/dL, P < .001), IgG1 (782.0 and 938.4 vs 592.4 mg/dL, P < .001), IgG2 (493.5 and 384.2 vs 305 mg/dL, P < .001), IgG3 (76.6 and 91.9 vs 55.9 mg/dL, P < .001), and IgG4 (140.4 and 53.6 vs 41.6 mg/dL, P < .001). Immunoglobin G subclass 4 concentrations were higher in males than those in females (56.3 vs 37.4 mg/dL, P < .001). Similar observations were made when comparing the proportions of patients with results outside of reference ranges and after stratifying by diagnosis.
CONCLUSION
Immunoglobin G and IgG subclass concentrations differ according to sex and race. These findings may have implications for the interpretation of these test results but require confirmation in diverse, healthy populations.

Identifiants

pubmed: 32224206
pii: S1081-1206(20)30176-9
doi: 10.1016/j.anai.2020.03.018
pmc: PMC7387162
mid: NIHMS1579916
pii:
doi:

Substances chimiques

Immunoglobulin G 0
Immunoglobulin Isotypes 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-195.e2

Subventions

Organisme : NIAMS NIH HHS
ID : K23 AR073334
Pays : United States
Organisme : NIAMS NIH HHS
ID : L30 AR070520
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144295
Pays : United States

Informations de copyright

Copyright © 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

Clin Chim Acta. 2012 Oct 9;413(19-20):1612-7
pubmed: 22584028
Clin Rheumatol. 2017 Dec;36(12):2769-2774
pubmed: 28540606
J Allergy Clin Immunol. 2015 Nov;136(5):1186-205.e1-78
pubmed: 26371839
Clin Infect Dis. 2008 May 15;46(10):1547-54
pubmed: 18419489
J Allergy Clin Immunol. 2003 May;111(5):1008-16
pubmed: 12743565
Pediatr Infect Dis J. 1988 May;7(5 Suppl):S17-21
pubmed: 3041356
J Periodontal Res. 1997 May;32(4):381-7
pubmed: 9210092
Vaccine. 2014 Apr 7;32(17):1946-53
pubmed: 24530932
Ann N Y Acad Sci. 1983 Jun 30;409:321-32
pubmed: 6191613
J Am Soc Nephrol. 2014 Aug;25(8):1834-41
pubmed: 24722442
Clin Exp Immunol. 2008 Jan;151(1):42-50
pubmed: 18005364
Ann Rheum Dis. 2015 Jan;74(1):14-8
pubmed: 24651618
J Allergy Clin Immunol. 2017 Jul;140(1):257-265.e11
pubmed: 28069248
Clin Lab. 2017 Sep 1;63(9):1323-1337
pubmed: 28879714
Chest. 2000 May;117(5):1336-44
pubmed: 10807820
Health Serv Res. 2015 Apr;50(2):398-417
pubmed: 25219917
Arthritis Res Ther. 2017 Dec 01;19(1):262
pubmed: 29191210
Nephrol Dial Transplant. 2016 May;31(5):798-806
pubmed: 26932693
J Clin Immunol. 2014 Nov;34(8):954-61
pubmed: 25257253
J Clin Pathol. 1997 Oct;50(10):819-22
pubmed: 9462262
Lab Med. 2017 Nov 8;48(4):314-325
pubmed: 29126302
Am J Gastroenterol. 2016 May;111(5):733-43
pubmed: 27091321
Bull World Health Organ. 1975;52(2):179-85
pubmed: 1083305
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1277-1284
pubmed: 30557717
Clin Chem Lab Med. 2011 Oct 28;50(2):345-349
pubmed: 22035142
J Allergy Clin Immunol. 2004 Apr;113(4):747-55
pubmed: 15100683
Int J Endocrinol. 2015;2015:706843
pubmed: 25784936
J Clin Lab Anal. 1995;9(1):37-41
pubmed: 7722770
J Allergy Clin Immunol. 2009 Sep;124(3):447-53
pubmed: 19647861
Infect Immun. 1996 Jul;64(7):2500-5
pubmed: 8698472
Ann Rheum Dis. 2019 Mar;78(3):406-412
pubmed: 30612117
Curr Opin Pediatr. 1993 Dec;5(6):696-9
pubmed: 8124421
Am J Med Sci. 2018 Jan;355(1):61-66
pubmed: 29289265
JAMA. 2019 Jul 9;322(2):113-114
pubmed: 31169890

Auteurs

Tyler Harkness (T)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts.

Xiaoqing Fu (X)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts.

Yuqing Zhang (Y)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts.

Hyon K Choi (HK)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

John H Stone (JH)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Kimberly G Blumenthal (KG)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Zachary S Wallace (ZS)

Clinical Epidemiology Program, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: zswallace@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH